Crossmark Global Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,540
| Closed | -$219K | – | 1304 |
|
|
2019
Q4 | $219K | Buy |
+3,540
| New | +$219K | 0.01% | 1297 |
|
|
2018
Q4 | – | Sell |
-7,950
| Closed | -$679K | – | 1440 |
|
|
2018
Q3 | $679K | Sell |
7,950
-150
| -2% | -$12.8K | 0.02% | 773 |
|
|
2018
Q2 | $939K | Buy |
8,100
+420
| +5% | +$48.7K | 0.03% | 620 |
|
|
2018
Q1 | $621K | Sell |
7,680
-620
| -7% | -$50.1K | 0.02% | 797 |
|
|
2017
Q4 | $487K | Buy |
8,300
+2,130
| +35% | +$125K | 0.01% | 1023 |
|
|
2017
Q3 | $289K | Buy |
+6,170
| New | +$289K | 0.01% | 1341 |
|
|
2016
Q3 | $289K | Buy |
+6,170
| New | +$289K | 0.01% | 1341 |
|